Randy Howe

Myeloma: OBI Rivals IV Isatuximab, Ups Patient Comfort

June 16, 2025

TOPLINE:A novel, single-use on-body injector (OBI) for isatuximab in multiple myeloma is noninferior to the standard intravenous (IV) formulation in...

Randy Howe

Myeloma: OBI Rivals IV Isatuximab, Ups Patient Comfort

FDA approves UroGen’s Zusduri to treat recurrent bladder cancer

Doctors Can Spot Diabetes and Cancer in Your Eyes. Are You Missing the Signs?

The Side of Type 1 Diabetes That Most Men Don’t Talk About

AAP updates recommendations for adolescent contraceptive counseling

A fresh look at TikTok: Short food videos encourage long-term healthy eating habits in teens

The 9 Best Carry-On Backpacks of 2025, Tested by Editors

Scientists achieve record-breaking growth in miniature, functional liver models

Kirikiri Customs Boosts Revenue by 61%, Hands Over Expired Drugs to NAFDAC

Covid Worsened Shortages of Doctors and Nurses. Five Years On, Rural Hospitals Still Struggle.

Watch: Why Insurance Companies Are Denying Coverage for Prosthetic Limbs

FDA approves UroGen’s Zusduri to treat recurrent bladder cancer

Doctors Can Spot Diabetes and Cancer in Your Eyes. Are You Missing the Signs?

The Side of Type 1 Diabetes That Most Men Don’t Talk About

AAP updates recommendations for adolescent contraceptive counseling

A fresh look at TikTok: Short food videos encourage long-term healthy eating habits in teens

About PhaMed

Recent News

You may have missed

About PhaMed

Recent News

Categories